CELESTICA $CLS Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $5.83B (Est. $5.46B) 🟢; vs $3.19B LY 🔹 Adj. EPS: $3.30 (Est. $2.97) 🟢; vs $1.58 LY 🔹 Adj. Operating Margin: 8.5%; vs 7.6% LY 🔹 Adj. Oper Earnings: $496.1M (Est. $459M) 🟢 FY26 Guide: 🔹 Revenue: $21.00B (Est. $20.61B) 🟢; from $20.5B 🔹 Adj. EPS: $11.55 (Est. $11.18) 🟢; from $11.30 🔹 Adj. Operating Margin: 8.4%; unchanged 🔹 Free Cash Flow: $460M; from $600M FY27 Guide: 🔹 Revenue: $40.00B (Est. $35.7B) 🟢 🔹 Adj. EPS: $21.50 (Est. $19.66) 🟢 🔹 Adj. Operating Margin: 9.0% 🔹 Capital Expenditures: $1.5B-$2.0B Q4 Guide: 🔹 Revenue: $6.28B-$6.58B (Est. $6.39B) 🟡 🔹 Adj. EPS: $3.37-$3.57 (Est. $3.50) 🟡 🔹 Adj. Operating Margin: 8.7% at midpoint Cash Flow: 🔹 Free Cash Flow: $127.5M; vs $88.9M LY 🔹 PP&E Purchases: $262.2M; vs $37.3M LY Segment Revenue (YoY): 🔹 CCS: $4.87B; +102% 🔹 ATS: $960M; +23% 🔹 HPS Revenue: ~$2.3B; +70% Segment Margin: 🔹 CCS Margin: 8.9%; vs 8.3% LY 🔹 ATS Margin: 6.6%; vs 5.5% LY Other Q3 Metrics: 🔹 GAAP EPS: $3.26; vs $2.31 LY 🔹 Adj. ROIC: 64.7%; vs 37.5% LY Key Updates: 🔹 Total Return Swap Impact on GAAP EPS: -$0.03/share negative (pre-tax) 🔹 SBC, Amortization & Restructuring Charge on GAAP EPS: $0.26/share (pre-tax) 🔹 Public Offering: $3.45B aggregate gross proceeds Comments: 🔸 “We are also pleased to provide our initial 2027 annual outlook, with revenue of $40.0 billion, up 90%, record adjusted operating margin (non-GAAP)* of 9.0% and adjusted EPS (non-GAAP)* of $21.50.” 🔸 “The demand environment continues to be very robust, supporting our 2027 revenue outlook, with customer demand forecasts meaningfully higher for 2028.”